great buy opportunity
in for ASCO.
no comparison LOL
and bankrupt LOL
GSK shingles vaccine shows benefits across all age groupsReuters
a good buy here .
will be the cyber security leader
The Street: SGYP Drug Better Tolerated Than IRWD * Posted
Shares of Synergy are up on positive plecanatide results, the drug is better tolerated than Linzess, a competing chronic constipation drug already approved and marketed by Ironwood Pharmaceuticals (IRWD - Get Report)
By: Brent Kenell
Fitbit has unbelievable growth and is already profitable, which is a big deal for a newly public company.
The valuation is attractive, too. GoPro (GPRO) and Under Armour (UA) both have slower growth rates, yet
have higher valuations that Fitbit. If Fitbit traded with the same valuation as Under Armour, it would be $72.
Business Wire 4/8/15
CyberArk Announces Release Date of First Quarter 2015 Financial Results
CyberArk Software Ltd. (CYBR), the company that protects organizations from cyber attacks that have made their way inside the network perimeter, today announced that it will report its first quarter 2015 financial results after the U.S. financial markets close on Thursday, May 7, 2015.
That's what it is folks.